Rabusertib (LY2603618)

Rabusertib (LY2603618, IC-83) is a highly selective Chk1 inhibitor with potential anti-tumor activity in a cell-free assay. IC50=7 nM, showing approximately 100-fold more potent against Chk1 than against any of the other protein kinases evaluated. Rabusertib (LY2603618) induces cell cycle arrest, DNA damage response and autophagy in cancer cells. Rabusertib (LY2603618) induces bak-dependent apoptosis in AML cell lines.

Price Not Available 10mM/1mL Rabusertib (LY2603618) Supplier Page

Trivial name	IC-83
Catalog Number	S2626
Molecular Formula	C26H44O4
CAS#	911222-45-2
Inchi	InChI=1S/C26H44O4/c1-5-17-21-14-16(27)10-12-26(21,4)20-11-13-25(3)18(15(2)6-9-22(28)29)7-8-19(25)23(20)24(17)30/h15-21,23-24,27,30H,5-14H2,1-4H3,(H,28,29)/t15-,16-,17-,18-,19?,20?,21+,23?,24-,25-,26-/ m1/s1
Inchi Key	ZXERDUOLZKYMJM-AMGBFIHRSA-N
SMILES	CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O
Size	10mM/1mL
Supplier Page	http://www.selleckchem.com/products/LY2603618-IC-83.html
Additional Information	https://file.selleck.cn/downloads/struct/LY2603618-chemical-structure-s2626.gif